Newcells Biotech builds advanced human tissue models to improve drug discovery.
Newcastle-based life science specialists develop proprietary human stem cell and tissue models for preclinical drug discovery. Their technology helps evaluate the safety and efficacy of potential therapeutics prior to human trials.
Mike Nicholds
CEO
Mike brings leadership and commercial experience from biotechnology and business services, currently serving as chief executive officer at Newcells Biotech and managing director at Cels Business Services.
LinkedInAndrew Hair
Media contact
The seed follow-on round from existing backers Mercia and NorthStar Ventures will fund international expansion in the US and accelerate product launches.
